ArticleScientific reports2022

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants.

Daniel Junker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.